Public Health Leadership in Challenging Times: Learning from the Past and Preparing for the Future

TL;DR

Dr. Margaret Hamburg, former commissioner of the US Food and Drug Administration (FDA), discusses her experience in leading the FDA and the challenges she faced. She emphasizes the importance of trust, science-driven decision making, and global collaboration in public health.

Transcript

good afternoon and welcome to the voices and leadership a series focusing on science in leadership I am Betty Johnson and I have the privilege to direct this program and introduce today's guest dr. Margaret Hamburg is an internationally recognized leader in public health and medicine where she is known for advancing regulatory science and modernize... Read More

Key Insights

• 🖐️ The FDA oversees products that represent a significant portion of consumer spending and plays a crucial role in protecting public health.
• 🏛️ Building trust and confidence in regulatory agencies like the FDA is essential for their effective functioning.
• 🔬 Science-driven decision making and collaboration with academia and industry are crucial in advancing regulatory science and public health.
• 🧑‍⚕️ Communicating the relevance and importance of science to the general audience is a challenge but essential for making informed decisions and achieving public health goals.
• 💦 Balancing work and personal life is a continuous challenge for leaders, and delegating tasks and prioritizing are important skills to manage the workload successfully.
• 🌐 Global collaboration and addressing global challenges are necessary for promoting and protecting public health in a globalized world.
• 💊 Integrity and trustworthiness are essential qualities for effective leadership in public health and medicine.

Questions & Answers

Q: What were the greatest challenges Dr. Hamburg faced as the Commissioner of the FDA?

Dr. Hamburg mentions the broad range of products and activities she had to oversee, the treacherous interface of public health, science, medicine, and politics, and the pressure to make decisions that have a significant impact on individuals and families.

Q: How did Dr. Hamburg restore trust and confidence in the FDA?

Dr. Hamburg focused on opening up the agency to explain its work, building a strong scientific foundation for FDA's decisions, engaging with academia and industry scientists, and driving decisions based on the best available science.

Q: How did Dr. Hamburg break through to a general audience and communicate the importance of evidence in decision making?

She shares an example from her time as the Health Commissioner in New York City, where she used scientific data to convince then-Mayor Dinkins to support needle exchange programs, despite his initial opposition. This decision was based on evidence that needle exchange reduces HIV infection rates.

Q: What was Dr. Hamburg's leadership style during her tenure as FDA Commissioner?

Dr. Hamburg describes her leadership style as gracious, focused on listening and learning from others, moving towards consensus, and recognizing the importance of delegation. She also mentions being committed to the mission and purpose of the FDA.

Summary & Key Takeaways

• Dr. Margaret Hamburg served as the 21st commissioner of the US FDA from 2009 to 2015, where she focused on restoring trust and confidence in the agency, driving decisions based on science, and engaging with academia and industry.

• She faced challenges in overseeing a broad range of products and activities, working at the intersection of public health, science, medicine, and politics.

• Dr. Hamburg emphasizes the need to communicate the relevance and importance of science in decision making and shares how she broke through to a general audience by using evidence to support important decisions.